In this blog series, which is part of our recently launched Sustainability Hub, we’re speaking to chemical engineers across the world making a difference to make sustainable practices and products a reality and more accessible to all for the wider benefit of our society and globe.
Today on World Health Day (7 April 2022), John Civardi talks about his experience as a water engineer, and how water is being contaminated with pharmaceutical waste, which could lead to the development of drug-resistant bacteria. He also explains why it’s important for chemical engineers to help solve this issue for better treatment and cleaning of waterways, groundwater and other water sources to prevent future threats to humans, animals and the environment.
Addressing the need to generate new medicines and treatments for patients at a faster pace was something that UK consortium group – CPI, UCB Celltech, Lonza Pharma and Biotech, Horizon Discovery, Sphere Fluidics, and Alcyomics, have been developing over the past four years and earned them the IChemE Global Award 2019 in the Biotechnology Award category.
“If you involve chemical engineers earlier, you can get more manufacturable solutions earlier. It’s having that translational mindset in the project from an early stage, which makes a massive difference.”
The project incorporated various sectors of the biopharmaceutical industry together and working as team help advance the production and delivery of medication to patients more efficiently.
Three researchers at the University of Birmingham are battling it out to be crowned the winner of the university’s Philanthropic Research Project 2018.
The university has announced the finalists of its research project competition – selecting three that have the potential to change lives. Birmingham has committed to fundraising for the chosen winner over the next year, helping to drive their research forward to potential commercialisation opportunities – ultimately providing benefit to more people.
One of the finalists is Dr Sophie Cox from the Department of Chemical Engineering. Her project, Engineering new medical systems to fight antimicrobial resistance, is focused on combating antibiotic resistance, which is predicted to kill more people than cancer in a few years’ time.
Read on to find out more about her project, and how you can help her chances of winning the competition.
On 24 May 2016 at the Edinburgh International Conference Centre, Professor Jonathan Seville was inaugurated as IChemE President for 2016-17. The Executive Dean of Engineering at University of Surrey delivered his Presidential Address on the subject of relevance. Jonathan challenged us all to think: how will the Institution and the profession stay relevant in a world that is rapidly changing?
If you’ve ever had a tropical aquarium there’s a good chance you’ll have owned and been delighted by the vibrant colours of a darting Zebrafish.
What you may not know is that the Zebrafish has become a firm favourite of the research community. One reason for this is that Zebrafish embryos are completely transparent making them ideally suited for studying developmental processes as they occur.
As a general introduction to why Zebrafish are so attractive to the science community, take a look at this YouTube video produced by University College London (UCL).
If ever you try to explain what a chemical engineer does, comparing it to human anatomy may not be your first choice. But there are some useful analogies, for instance the kidney.
The main role of the kidneys is to filter waste products from the blood and convert them to urine. If the kidneys lose this ability, waste products can build up, which is potentially dangerous and can be life threatening.
It’s a principle used widely by chemical engineers to manage all kinds of human and industrial waste.
I think the relationship between chemical engineers and human anatomy is set to become more common over the next few years, and will improve the quality of life for millions of people.
The world of genetics is fascinating and there always seems an endless stream of findings and breakthroughs with the potential for predicting and treating health problems.
This month, research published in the New England Journal of Medicine indicated women with mutations in the PALB2 gene face a one in three chance of getting breast cancer by age 70.
A team at the Institute of Cancer Research, in London, have shown 14 separate genetic mutations can greatly increase the odds of aggressive prostate cancers and form the basis for genetic screening in a similar way to breast cancer in women.
Most of us are familiar and fascinated with ‘big-game’ animals like rhinos, elephants and tigers. Thankfully, they are now protected animals and their numbers have stabilised, but remain perilously low. For instance only around 3,000 tigers remain the in the wild.
By contrast, there are tens of millions of species of bacteria living in the wild. But even these are hard to capture and some are just as elusive as a Siberian Tiger.
Healthcare policy ebbs and flows on a regular basis, especially in countries where the state provides tax-payer funded services like here in the UK.
However, although medicines, equipment, communication and facilities have all generally improved over time, the basic management of healthcare services and the business models for delivering them often seem in a state of constant flux.
A good example is where healthcare is best provided – in homes, communities or large centralised hospitals. Generally, I think it is a combination of all of these, but there has been a trend over the past few decades to more community- and home-based services, especially for the elderly.